652 related articles for article (PubMed ID: 20100815)
41. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
42. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
[TBL] [Abstract][Full Text] [Related]
43. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3.
Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH
Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771
[TBL] [Abstract][Full Text] [Related]
44. Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide.
Tsotsou GE; Sideri A; Goyal A; Di Nardo G; Gilardi G
Chemistry; 2012 Mar; 18(12):3582-8. PubMed ID: 22337118
[TBL] [Abstract][Full Text] [Related]
45. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
[TBL] [Abstract][Full Text] [Related]
46. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
47. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
48. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
[TBL] [Abstract][Full Text] [Related]
49. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
[TBL] [Abstract][Full Text] [Related]
50. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants.
Uno T; Obe Y; Ogura C; Goto T; Yamamoto K; Nakamura M; Kanamaru K; Yamagata H; Imaishi H
Biopharm Drug Dispos; 2013 Mar; 34(2):87-97. PubMed ID: 23112005
[TBL] [Abstract][Full Text] [Related]
51. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
52. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
53. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
[TBL] [Abstract][Full Text] [Related]
54. Desaturation of alkylbenzenes by cytochrome P450(BM3) (CYP102A1).
Whitehouse CJ; Bell SG; Wong LL
Chemistry; 2008; 14(35):10905-8. PubMed ID: 19003834
[No Abstract] [Full Text] [Related]
55. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
[TBL] [Abstract][Full Text] [Related]
56. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold.
Ferrero VE; Andolfi L; Di Nardo G; Sadeghi SJ; Fantuzzi A; Cannistraro S; Gilardi G
Anal Chem; 2008 Nov; 80(22):8438-46. PubMed ID: 18947200
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.
Lussenburg BM; Babel LC; Vermeulen NP; Commandeur JN
Anal Biochem; 2005 Jun; 341(1):148-55. PubMed ID: 15866539
[TBL] [Abstract][Full Text] [Related]
58. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
59. Fluorescence detection of ligand binding to labeled cytochrome P450 BM3.
Ferrero VE; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
Dalton Trans; 2012 Feb; 41(7):2018-25. PubMed ID: 22180859
[TBL] [Abstract][Full Text] [Related]
60. Effect of mutations of ionic amino acids of cytochrome P450 1A2 on catalytic activities toward 7-ethoxycoumarin and methanol.
Mayuzumi H; Sambongi C; Hiroya K; Shimizu T; Tateishi T; Hatano M
Biochemistry; 1993 Jun; 32(21):5622-8. PubMed ID: 8504082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
